Target Validation Information
Target ID T50912
Target Name T-lymphocyte activation antigen CD86
Target Type
Successful
Drug Potency against Target Abatacept Drug Info Kd = 6.7 nM [553226]
References
Ref 553226Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol. 1996 Feb 1;156(3):1047-54.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.